Forums
Football
- News
- Schedule
- SEC Standings
- Roster
- Staff
- Class Breakdown
Recruiting
Sports
- Football
- Basketball
- Baseball
- Women's Basketball
- Soccer
- Softball
- Volleyball
Premium
Sponsors
- Sponsors
- Advertise With Us
United
More
- Podcasts
- Media
- TexAgs Live
- Post of the Day
- iOS App
- Search
- Store
- Pick-Off
- 12th Man Foundation
- Our Staff
- Contact Us
- Help Center

subscribe

| Register

Texas A&M Football

Press Conference: Elko, No. 6 Ags react to 31-9 win vs. Mississippi State

Behind a dominant running game, No. 6 Texas A&M is now 5-0 after beating Mississippi State in front of 108,572 at Kyle Field on Saturday night. Following A&M's "Operation Blackout" success, Mike Elko, Rueben Owens II, Daymion Sanford and Mario Craver spoke to the media.

By TexAgs

October 4, 2025

2.8k Views

1 Comment

Story Poster

PLAYING

Mike Elko

PLAYING

Rueben Owens II

PLAYING

Daymion Sanford

PLAYING

Mario Craver

Never miss the latest news from TexAgs!

Join our free email list

Tags

Mike Elko Press Conferences Texas A&M vs. Mississippi State Rueben Owens II Daymion Sanford Mario Craver Football Texas A&M Mississippi State 2025

More Football

See All →

No. 6 Aggies never flinch in second-half domination of Mississippi State

By Olin Buchanan

Photo Gallery: Successful 'Operation Blackout' moves No. 6 A&M to 5-0

By Will Huffman

TexAgs Post Game Wrap: No. 6 Texas A&M 31, Mississippi State 9

By David Nuño

FINAL from Kyle Field: No. 6 Texas A&M 31, Mississippi State 9

By TexAgs

Discussion from...

Press Conference: Elko, No. 6 Ags react to 31-9 win vs. Mississippi State

1,505 Views | 1 Replies | Last: 3 hrs ago by TAMU74

TAMU74

Joined: Mar 28, 2001

Posts: 7,992

User Profile Ignore User Stop Ignoring

How long do you want to ignore this user?

24 hours One week Permanently Cancel

12:04a, 10/5/25

AG

Congratulations on the win coach Elko, staff and players.
Keep it going

1

Page 1 of 1

Follow TexAgs

×

subscribe Verify your student status

See Subscription Benefits

Trial only available to users who have never subscribed or participated in a previous trial.